Impact of Icosapent Ethyl on Lipids, Blood Pressures, and Adverse Events in Cognitively Healthy Vete...
Impact of Icosapent Ethyl on Lipids, Blood Pressures, and Adverse Events in Cognitively Healthy Veterans Participating in the BRAVE Study
About this item
Full title
Author / Creator
Cardenas, Cecilia A. , Van Hulle, Carol A. , Zylstra, Hannah , Cronin, Kate , Cole, Aleshia , Beckman, Elena , Eierman, Allison C , Blazel, Madeleine , Lazar, Karen K , Johnson, Kevin M. , Rivera‐Rivera, Leonardo A. , Chapell, Richard , Zetterberg, Henrik , Gleason, Carey E. , Johnson, Sterling C. , Asthana, Sanjay and Carlsson, Cynthia M.
Publisher
Hoboken: John Wiley and Sons Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken: John Wiley and Sons Inc
Subjects
More information
Scope and Contents
Contents
Background
The omega‐3 fatty acid eicosapentaenoic acid (EPA) has positive benefits for cardiovascular risk, reducing inflammation and improving endothelial function. Evidence suggests that Icosapent ethyl, a purified form of EPA, can improve cardiovascular outcomes in at‐risk patients. Veterans are at higher risk for vascular dysfunction, a ris...
Alternative Titles
Full title
Impact of Icosapent Ethyl on Lipids, Blood Pressures, and Adverse Events in Cognitively Healthy Veterans Participating in the BRAVE Study
Authors, Artists and Contributors
Author / Creator
Van Hulle, Carol A.
Zylstra, Hannah
Cronin, Kate
Cole, Aleshia
Beckman, Elena
Eierman, Allison C
Blazel, Madeleine
Lazar, Karen K
Johnson, Kevin M.
Rivera‐Rivera, Leonardo A.
Chapell, Richard
Zetterberg, Henrik
Gleason, Carey E.
Johnson, Sterling C.
Asthana, Sanjay
Carlsson, Cynthia M.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11712387
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11712387
Other Identifiers
ISSN
1552-5260
E-ISSN
1552-5279
DOI
10.1002/alz.094881
